Suspicious Order Monitoring Requirement

Per the DEA 21 CFR 1301.74b, the suspicious order monitoring requirement regulates prescription orders being filled.

The Drug Enforcement Administration requires all manufacturers, distributors and dispensers of controlled substances register with the agency. Before distributing the substance, the registrant needs to make a good faith inquiry, either with the Administration or with the appropriate State controlled substances agency to determine that person can possess the controlled substances.


Two Missions Come Together As One

The DEA's Mission:

Is to enforce the controlled substances laws and regulations of the United States and bring to the criminal and civil justice system of the United States, or any other competent jurisdiction. Those organizations involved in the growing, manufacture, or distribution of controlled substances appearing in or destined for illicit traffic in the United States.

e-SupplyLink's Mission:

Is to improve the health and welfare of the American Public with the use of compliance software to implement best practices for businesses operating within the pharmaceutical supply chain.

How SOMLink enforces DEA regulations:


Countdown to DEA's National Take Back Day: Oct. 27, 2018

Results: October 2018 16th National Take Back

  • Total Law Enforcement Participation: 4,770
  • Total Collection Sites: 5,839
  • Total Weight Collected: 914,236 lbs.  (457.12 Tons)